EXOZ — eXoZymes, Inc.
NASDAQ · Healthcare · Biotechnology
$6.50
-$0.23 (-3.42%)
eXoZymes, Inc. (EXOZ) is a biotechnology company listed on NASDAQ. It is led by Michael Heltzen, based in 750 Royal Oaks Drive, Monrovia, CA, United States, 91016, with about 32 employees. eXoZymes, Inc. operates as a development stage biotechnology company. It focuses on the development of enzyme modules and cell-free exozyme biosolutions for synthetic biology manufacturing. The company was formerly known as Invizyne Technologies, Inc. and changed its name to eXoZymes, Inc. in February 2025. eXoZymes, Inc. was incorporated in 2014 and is headquartered in Monrovia, California.
Net income was -$2.3M. EXOZ currently screens at market cap $83.5M.
Use this EXOZ page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the EXOZ quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the EXOZ SEC filings page. Lician reads the product cache first so this HTML stays unique to eXoZymes, Inc. even when a live quote feed is slow.
About eXoZymes, Inc.
eXoZymes, Inc. operates as a development stage biotechnology company. It focuses on the development of enzyme modules and cell-free exozyme biosolutions for synthetic biology manufacturing. The company was formerly known as Invizyne Technologies, Inc. and changed its name to eXoZymes, Inc. in February 2025. eXoZymes, Inc. was incorporated in 2014 and is headquartered in Monrovia, California.
EXOZ Key Statistics
Market Cap
$83.48M
Volume
3,212
Previous Close
$6.95
Day Range
$6.45 – $7.80
EPS
-$0.89
Revenue
$0.00
Net Income
-$5.86M
Gross Profit
$0.00
Free Cash Flow
$0.00
Revenue Growth
-100.0%
Employees
32
EXOZ Financials
Annual income statement in USD. Latest reported periods first.
| Line | FY2024 | FY2023 |
|---|---|---|
| Revenue | $0.00 | $70.07K |
| Cost of Revenue | $0.00 | $0.00 |
| Gross Profit | $0.00 | $0.00 |
| Operating Income | $0.00 | $0.00 |
| Net Income | -$5.86M | -$2.04M |
| EPS (Diluted) | -$0.89 | -$0.33 |
Total Assets
$13.03M
Total Debt
$0.00
Shareholders' Equity
$0.00
Cash & Equivalents
$9.72M
Operating Cash Flow
-$8.51M
Free Cash Flow
$0.00
eXoZymes, Inc. Company Information
- President & CEO
- Michael Heltzen
- Headquarters
- 750 Royal Oaks Drive, Monrovia, CA, United States, 91016
- Website
- www.exozymes.com
- Phone
- 626 415 1488
- IPO / Founded
- 2024-11-13
- Sector
- Healthcare
- Industry
- Biotechnology